Skip to main content

ADVERTISEMENT

screening guidelines

Pharma Insights
09/06/2016
Jeremy Schafer, PharmD, MBA
Controversy over the lack of a survival benefit associated with early diagnosis of prostate cancer through prostate-specific antigen (PSA) screening has led to uncertainty in the determination of PSA coverage and its...
Controversy over the lack of a survival benefit associated with early diagnosis of prostate cancer through prostate-specific antigen (PSA) screening has led to uncertainty in the determination of PSA coverage and its...
...
09/06/2016
Journal of Clinical Pathways